NCT07501117
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07501117
Title Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Inge Marie Svane
Indications
Therapies
Age Groups: adult | senior
Covered Countries DNK

Facility Status City State Zip Country Details
National Center for Cancer Immune Therapy, Department of Oncology, Herlev Hospital Herlev Herlev 2730 Denmark Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field